Biomea’s Novel Diabetes Candidate Placed On FDA Hold

 
• By Joseph Haas
  
Delay
Biomea's diabetes candidate ran into a delay as the FDA placed two trials on hold • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D